Terms: = Breast cancer AND DICER1, Dicer, 23405, ENSG00000100697, KIAA0928, HERNA, Q9UPY3, K12H4_8-LIKE
121 results:
1. Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of dicer to accelerate triple-negative breast cancer progression.
Chen SY; Zhang FL; Zhang YL; Liao L; Deng L; Shao ZM; Liu GY; Li DQ
Cancer Lett; 2024 Apr; 586():216672. PubMed ID: 38280476
[TBL] [Abstract] [Full Text] [Related]
2. Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord-stromal tumors. Results of the TGM13 National Registry.
Fuentes C; Ouldbey Y; Orbach D; Sudour-Bonnange H; Verité C; Rome A; Dumesnil C; Thebaud E; Hameury F; Dijoud F; Chabaud S; Cote MD; Fresneau B; Faure-Conter C
Pediatr Blood Cancer; 2024 Apr; 71(4):e30864. PubMed ID: 38259036
[TBL] [Abstract] [Full Text] [Related]
3. Novel Pathways between Invasiveness Modulators in breast cancer Single Cells.
Eliceiri GL
Crit Rev Eukaryot Gene Expr; 2024; 34(2):73-75. PubMed ID: 38073443
[TBL] [Abstract] [Full Text] [Related]
4. Role of tRNA-derived small RNAs(tsRNAs) in the diagnosis and treatment of malignant tumours.
Mao M; Chen W; Huang X; Ye D
Cell Commun Signal; 2023 Jul; 21(1):178. PubMed ID: 37480078
[TBL] [Abstract] [Full Text] [Related]
5. Ovarian epithelioid malignant peripheral nerve sheath tumor with EWSR1-CREM fusion: A case report and literature review.
Li S; Hong R; Wang X; Yang J
Int J Gynaecol Obstet; 2023 Nov; 163(2):521-527. PubMed ID: 37151162
[TBL] [Abstract] [Full Text] [Related]
6. Chaperone-mediated autophagy degrade dicer to promote breast cancer metastasis.
Su CM; Hsu TW; Chen HA; Wang WY; Huang CY; Hung CC; Yeh MH; Su YH; Huang MT; Liao PH
J Cell Physiol; 2023 Apr; 238(4):829-841. PubMed ID: 36815383
[TBL] [Abstract] [Full Text] [Related]
7. dicer-mediated miR-200b expression contributes to cell migratory/invasive abilities and cancer stem cells properties of breast cancer cells.
Hsu TW; Chen HA; Liao PH; Su YH; Chiu CF; Huang CY; Lin YJ; Hung CC; Yeh MH; Sung SY; Su CM
Aging (Albany NY); 2022 Aug; 14(16):6520-6536. PubMed ID: 35951366
[TBL] [Abstract] [Full Text] [Related]
8. Linoleic-acid-substituted polyethylenimine to silence heat shock protein 90B1 (HSP90B1) to inhibit migration of breast cancer cells.
Meenakshi Sundaram DN; Kc RB; Uludağ H
J Gene Med; 2022 Jun; 24(6):e3419. PubMed ID: 35373897
[TBL] [Abstract] [Full Text] [Related]
9. Rare Hereditary Gynecological cancer Syndromes.
Watanabe T; Soeda S; Endo Y; Okabe C; Sato T; Kamo N; Ueda M; Kojima M; Furukawa S; Nishigori H; Takahashi T; Fujimori K
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163487
[TBL] [Abstract] [Full Text] [Related]
10. Gynecological lesions in hereditary cancer predisposition syndromes.
Dundr P; Cibula D; Foretová L; Macek M; Kopečková K; Petruželka L; Němejcová K; Bártů M; Hojný J; Hájková N; Jakša R; Janega P; Stružinská I
Cesk Patol; 2021; 57(2):96-104. PubMed ID: 34275319
[TBL] [Abstract] [Full Text] [Related]
11. lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell.
Huang Y; Zhou Z; Zhang J; Hao Z; He Y; Wu Z; Song Y; Yuan K; Zheng S; Zhao Q; Li T; Wang B
J Cell Mol Med; 2021 Aug; 25(15):7135-7145. PubMed ID: 34164906
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication.
Sheng X; Dai H; Du Y; Peng J; Sha R; Yang F; Zhou L; Lin Y; Xu S; Wu Y; Yin W; Lu J
J Exp Clin Cancer Res; 2021 Jun; 40(1):205. PubMed ID: 34162418
[TBL] [Abstract] [Full Text] [Related]
13. WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.
Tabatabaeian H; Lim SK; Chu T; Seah SH; Lim YP
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34117091
[TBL] [Abstract] [Full Text] [Related]
14. Macrofollicular variant follicular thyroid tumors are dicer1 mutated and exhibit distinct histological features.
Juhlin CC; Stenman A; Zedenius J
Histopathology; 2021 Oct; 79(4):661-666. PubMed ID: 34008223
[TBL] [Abstract] [Full Text] [Related]
15. Non-medullary Thyroid cancer Susceptibility Genes: Evidence and Disease Spectrum.
Zhou J; Singh P; Yin K; Wang J; Bao Y; Wu M; Pathak K; McKinley SK; Braun D; Lubitz CC; Hughes KS
Ann Surg Oncol; 2021 Oct; 28(11):6590-6600. PubMed ID: 33660127
[TBL] [Abstract] [Full Text] [Related]
16. Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer.
Ye Z; Abdelmoaty MM; Ambardekar VV; Curran SM; Dyavar SR; Arnold LL; Cohen SM; Kumar D; Alnouti Y; Coulter DW; Singh RK; Vetro JA
Nanomedicine; 2021 Apr; 33():102363. PubMed ID: 33545405
[TBL] [Abstract] [Full Text] [Related]
17. A complex dicer1 syndrome phenotype associated with a germline pathogenic variant affecting the RNase IIIa domain of dicer1.
Pontén E; Frisk S; Taylan F; Vaz R; Wessman S; de Kock L; Pal N; Foulkes WD; Lagerstedt-Robinson K; Nordgren A
J Med Genet; 2022 Feb; 59(2):141-146. PubMed ID: 33208384
[TBL] [Abstract] [Full Text] [Related]
18. Matrine Inhibitory Effect on Self-renewal and Re-sensitization of 5-FU Resistant NSCLC Stem Cells were through Let-7b dependent Downregulation of CCND1.
Li X; Wang M; Du N; Liang T; Xiao GD; Li K; Wang JC; Xu CW; Peng ZY; Tang SC; Sun X
Cell Cycle; 2020 Dec; 19(23):3249-3259. PubMed ID: 33164645
[TBL] [Abstract] [Full Text] [Related]
19. Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancer.
Guenter J; Abadi S; Lim H; Chia S; Woods R; Jones M; Rebic N; Renouf DJ; Laskin J; Marra M
J Oncol Pharm Pract; 2021 Sep; 27(6):1371-1381. PubMed ID: 32847480
[TBL] [Abstract] [Full Text] [Related]
20. Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor dicer.
Lim SK; Tabatabaeian H; Lu SY; Kang SA; Sundaram GM; Sampath P; Chan SW; Hong WJ; Lim YP
Cell Death Dis; 2020 Aug; 11(8):669. PubMed ID: 32820148
[TBL] [Abstract] [Full Text] [Related]
[Next]
